CD27 anticorps (AA 161-175)

N° du produit ABIN2613401

Cet anticorps Chèvre Polyclonal détecte spécifiquement CD27 dans WB et ELISA. Il présente une réactivité envers Humain.

Aperçu rapide pour CD27 anticorps (AA 161-175) (ABIN2613401)

Antigène: CD27 (CD27 Molecule (CD27))

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp CD27 est non-conjugé

Application: Western Blotting (WB), ELISA

Classe de qualité: Verified

Détail du produit anti-CD27 anticorps

Épitope: AA 161-175

Fonction: CD27 (aa161-175)

Séquence: QTLADFRQLP ARTLS

Réactivité croisée: Humain

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Isotype: IgG

Information d'application

Indications d'application:

Western Blot: Approx 45 kDa band observed in Human Spleen, Tonsil and Thymus lysates (calculated MW of 29.2 kDa according to NP_001233.1). The observed molecular weight corresponds to the glycosylated form. Recommended concentration: 0.3-1 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:128000.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Minimize freezing and thawing.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Détails sur CD27

Antigène: CD27 (CD27 Molecule (CD27))

Autre désignation: CD27

Sujet: CD27, CD27 Molecule, S152, S152. LPFS2, T14, TNFRSF7, Tp55, CD27 antigen, CD27L receptor, T cell activation antigen S152, T-cell activation antigen CD27, tumor necrosis factor receptor superfamily, member 7

ID gène: 939

NCBI Accession: NP_001233

Pathways: Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints